Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey

被引:39
作者
Aybek, H. [1 ]
Ercan, F.
Aslan, D.
Sahiner, T.
机构
[1] Pamukkale Univ, Tip Fak, Biyokimya Anabilim Dali, Morfoloji Binasi Kinikli,Med Sch,Dept Biochem, Denizli, Turkey
[2] Pamukkale Univ, Sch Med, Dept Neurol, Denizli, Turkey
关键词
oxidative stress; apolipoprotein E4; Alzheimer's disease; polymorphism;
D O I
10.1016/j.clinbiochem.2006.09.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: The aim of the present study was to determine the Apolipoprotein E (APOE) 4 allele frequency of patients with late-onset Alzheimer's disease (AD) and to determine the effects of oxidant-antioxidant balance on AD. Design and methods: PCR-RFLP was undertaken in 62 cases with AD and 56 aged-matched controls. Activities of reduced glutathione (GSH) and malondialdehyde (MDA) concentration were measured in same groups. Results: Patients with at least one E4 allele genotype were significantly different in patients with AD (21%) than controls (9%) (p=0.01). Serum MDA levels were significantly different between AD patients and Control group (p=0.0001). There was no significant difference in serum GSH levels between AD patients and C groups. Conclusion: These results confirmed that the APOE4 allele occurs frequently in late onset AD compared with normal controls. Also elevated MDA levels are likely an essential factor in the pathogenesis and neuronal damage of AD. (c) 2006 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 42 条
[1]   OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[2]  
[Anonymous], 2001, Anal Biochem
[3]   EVIDENCE OF AN OXIDATIVE CHALLENGE IN THE ALZHEIMERS BRAIN [J].
BALAZS, L ;
LEON, M .
NEUROCHEMICAL RESEARCH, 1994, 19 (09) :1131-1137
[4]   Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis [J].
Baskol, G ;
Demir, H ;
Baskol, M ;
Kilic, E ;
Ates, F ;
Kocer, D ;
Muhtaroglu, S .
CLINICAL BIOCHEMISTRY, 2005, 38 (10) :951-955
[5]   AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1995, 38 (03) :357-366
[6]   Apolipoprotein E:: a major piece in the Alzheimer's disease puzzle [J].
Cedazo-Mínguez, A ;
Cowburn, RF .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2001, 5 (03) :254-266
[7]   Oxidative stress and Alzheimer disease [J].
Christen, Y .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 71 (02) :621S-629S
[8]   α2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease [J].
Depboylu, Candan ;
Lohmueller, Frank ;
Du, Yansheng ;
Riemenschneider, Matthias ;
Kurz, Alexander ;
Gasser, Thomas ;
Mueller, Ulrich ;
Dodel, Richard C. .
NEUROSCIENCE LETTERS, 2006, 400 (03) :187-190
[9]   Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease [J].
Guidi, I ;
Galimberti, D ;
Lonati, S ;
Novembrino, C ;
Bamonti, F ;
Tiriticco, M ;
Fenoglio, C ;
Venturelli, E ;
Baron, P ;
Bresolin, N ;
Scarpini, E .
NEUROBIOLOGY OF AGING, 2006, 27 (02) :262-269
[10]  
GUNGEN C, 1999, 9 C INT PSYCH ASS AU